查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496025

全球皮下注射针市场：2024-2029 年预测

Global Hypodermic Needle Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 126 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计在预测期内，皮下注射针市场将以 6.42% 的年复合成长率增长，市场规模将从 2022 年的 3,034,881,000 美元达到 2029 年的 4,690,217,000 美元。

皮下注射针是一种医疗器械，用于通常透过皮下、肌肉或静脉注射将物质注射到体内或从体内提取液体。皮下注射针由一根带有锋利尖端的中空圆形空管和柱塞组成，可以精确组织药物、疫苗接种以及血液和其他液体的抽取。

全球皮下注射针广告涉及医疗保健行业使用的皮下注射针的製造、分销和销售。市场的主要观点包括安全针头、非安全针头、应用程式、最终用户、地理接近性、管理环境、未使用的改进、行业主要参与者和开放的福利活动。安全针头着重医护人员安全等方面，降低针刺伤害的风险。

非安全针是没有额外安全部件的传统针。全球皮下注射针市场充满活力，并受到创新进步、医疗保健方法以及需要在恢復性医疗干预中使用皮下注射针的疾病流行等因素的影响。

市场驱动因素：

  • 糖尿病盛行率的增加预计将推动皮下注射针市场的成长。

由于全球糖尿病盛行率不断上升，预计该市场将在未来几年获得成长动力。根据国际糖尿病联盟提供的信息，到2021年，大约有5.37亿20岁至79岁年龄层的成年人将患有糖尿病多年。此外，预计到 2030 年，糖尿病患者人数将增至 6.43 亿，到 2045 年将增至 7.83 亿。

全球糖尿病支出的增加预计将大幅增加先进药物输送解决方案的采用。许多公司和企业正在为糖尿病患者提供先进和新颖的解决方案，例如将针插入患者体内来轻鬆输送药物。

  • 由于各种公司的存在，竞争分析的增加可能会加强皮下注射针市场。

近年来，一些公司和企业对市场产生了重大影响。随着公司倾向提高其竞争优势和全球整体市场占有率，预计未来几年研发支出将大幅增加。 Iskcon Surgicals 是该市场的主要企业之一，向其客户供应和销售一次性皮下注射针。

该公司表示，其针头采用高精度抛光、硅化和超音波清洗技术製造。该公司的产品已通过ISO认证。其他公司也为其客户提供先进的皮下注射针。

例如，NIPRO 是最大的针製造商之一，每年生产约 110 亿支针。该公司声明其产品并非以 PVC 或乳胶形式製造。该公司还提供各种长度和尺寸的皮下注射针。这些新兴市场的开拓和趋势预计将在预测期内在市场中发挥重要作用。

  • 气喘和慢性病发病率的增加预计将推动皮下注射针市场的发展。

由于全球气喘盛行率不断上升，皮下注射针的使用预计将在预测期内急剧增加。根据世界卫生组织（WHO）资讯显示，气喘进一步被纳入世界卫生组织《预防和控制非传染性疾病（NCD）全球行动计画》和联合国2030年永续发展计画。

世卫组织也采取多项措施改善低收入和中等收入国家的药品运输。随着工业化的扩大，人们对高污染的担忧，这是导致气喘患者盛行率增加的主要因素之一。因此，我们预计在预测期内皮下注射针和其他药物输送产品的采用将会增加。

由于全球慢性感染疾病的流行，该行业预计将激增。预计这种增长将推动针头和注射器的采用，它们似乎能够可靠地将药物输送到身体系统。此外，疫苗接种率的提高预计也将推动全球对新註射剂的需求。

  • 各种有利的政府法规预计将促进皮下注射针市场的成长。

多种糖尿病和气喘患者使用皮下注射针。这些患者需要对药物和液体脱敏，以防特定的不良反应。世界各国政府都制定了指令和法律，允许患者携带皮下注射针而不受重大限制。例如，2021 年 3 月，美国马里兰州参议院报告通过了一项新法案，将分发和拥有皮下注射针合法化。

此外，2021 年 10 月，纽约州政府报告称通过了一项法案，该法案将使该州皮下注射针的分销和销售合法化。根据这项新法案，皮下注射针将不再被视为医疗器材。政府表示，引入新立法是为了让人们更容易使用药物传输系统。

公司产品

  • B Braun(TM)皮下注射针- B Braun(TM)皮下注射针具有光滑的表面、轻薄的硅胶涂层、自研磨抛光工艺、低摩擦润滑、透明的针座设计、符合ISO 6009 的颜色编码针座、广泛的直径和长度是为了患者的舒适度而设计的。
  • SafeTouch皮下注射针- Nipro 的 SafeTouch 皮下注射皮下注射针是一款易于使用的高品质产品，透过透明的安全装置将针头锁定在其盖内，从而降低患者和医疗保健专业人员被针刺伤的风险。
  • Monoject(TM) 皮下注射安全针 - Cardinal Health Inc. 的 Monoject(TM) 皮下注射安全针是一种易于使用的单手设备，只需拇指即可固定，提高了临床医生的舒适度和信心。采用双锁定铰链臂技术，确保使用过程中和废弃后的安全。它还具有可逆的声音和触觉咔嗒声，以确保安全启动。无菌、一次性使用且独立包装，对临床医生来说是方便且安全的选择。

主要进展

  • 2023 年 5 月 - 确保光滑表面和精确斜角的高性能磨料对于皮下注射针的生产至关重要。 Norton Abrasives 提供切割、研磨和抛光工具，可提供卓越的效果并提高流程效率和患者舒适度。
  • 2023 年 1 月 - MTD 集团的 DropSafeTM SicuraTM 被动安全针头获得 FDA 批准，用于肌肉内和皮下注射疫苗和药物。该针头旨在消除针刺伤害并提供完全安全的注射体验。针头受到透明防护罩的保护，注射后会自动锁定，无需医疗保健专业人员逐步启动。该设备满足了美国未满足的提高安全性的需求，正在等待 CE 认证。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球皮下注射针市场：按类型

  • 介绍
  • 安全针
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 非安全针
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章全球皮下注射针市场：依应用分类

  • 介绍
  • 疫苗接种
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 药物输送
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 体液样本采集
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章全球皮下注射针市场：依最终用户分类

  • 介绍
  • 医院和诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 门诊治疗中心
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章全球皮下注射针市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • B. Braun Melsungen AG
  • NIPRO
  • Cardinal Health Inc.
  • Terumo Medical Corporation
  • Smith's Group Plc
  • BD
  • Iscon Surgicals Ltd.
  • Narang Medical Ltd.
  • Medline Industries Inc.
  • Dynarex Corporation
简介目录
Product Code: KSI061611904

The global hypodermic needle market is expected to grow at a compound annual growth rate of 6.42% over the forecast period to reach a market size of US$4,690.217 million in 2029, from US$3,034.881 million in 2022.

A hypodermic needle is a medical instrument utilized for infusing substances or extricating liquids from the body, ordinarily through subcutaneous, intramuscular, or intravenous courses. It comprises a hollow, round, and empty tube with a sharp tip and plunger, permitting for exact organization of drugs, immunizations, or withdrawal of blood or other liquids.

The worldwide hypodermic needle advertise includes the manufacturing, distribution, and selling of hypodermic needles utilized within the healthcare industry. Key viewpoints of the market include safety needles, non-safety needles, applications, end-users, geographical nearness, administrative environment, unused improvements, industry key players, and open well-being activities. Safety needles focus on aspects like healthcare employee safety, lessening the hazard of needlestick wounds.

Non-safety needles are conventional needles without extra security components. The worldwide hypodermic needle market is energetic and affected by components such as innovative headways, healthcare approaches, and the predominance of maladies that require the utilize of hypodermic needles in restorative medical intercessions.

Market Drivers:

  • The increasing prevalence of diabetes is anticipated to boost the hypodermic needle market growth.

The market is predicted to experience a boost in the years ahead due to the increase in the prevalence rate of diabetes around the world. According to the information provided by the International Diabetes Federation, around 537 million adult individuals have been living with diabetes for years, between the ages of 20 and 79 category in the year 2021. Further, it has also been estimated that the global population living with diabetes is expected to grow to 643 million by 2030 and around 783 million by 2045.

Increasing global expenditure on diabetes has been expected to surge the adoption of advanced drug delivery solutions. Various companies and corporations have been offering advanced and novel solutions for diabetic patients, such as the easy delivery of drugs by needles in a patient's body.

  • An increase in competitive analysis due to various corporation presence would bolster the hypodermic needle market.

Several firms and corporations have been making a considerable impact in the market in the past few years. The increasing expenditure on research and development was expected to surge in the next few years as corporations tend to increase their competitive advantage and overall market share globally. Iscon Surgicals Ltd., one of the key players in the market, has been providing and selling disposable hypodermic needles to its customers.

The company stated that its needle had been produced through high and advanced precision grinding, siliconization, and ultrasonic cleaning. The company's products are ISO Certified. Other corporations have been offering advanced hypodermic needles for their customers.

For instance, NIPRO, one of the largest needle manufacturers, produces around 11 billion units annually. The company stated that its products are not manufactured as PVC or latex. It also offers hypodermic needles in different lengths and sizes. These developments and trends are expected to play a significant role in the market during the forecast period.

  • The rising rate of asthma and chronic disease is expected to propel the hypodermic needle market.

Hypodermic needle utilization is anticipated to surge within the projected period due to the expanding rate of asthma, around the world. According to the information given by the World Wellbeing Organisation (WHO), asthma is additionally included in the WHO Worldwide Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Plan for Sustainable Development.

The WHO has also been undertaking a few measures to upgrade the drug conveyance segment in lower and middle-income nations. With expanding industrialization, there has been a concern around high contamination, which has been one of the major components of the expanding prevalence rate of asthmatic patients. Subsequently, it is anticipated to improve the adoption of hypodermic needles and other drug-delivery products within the projected time period.

The industry is anticipated to surge due to the rise in the predominance rate of chronic infections around the world. This increment is anticipated to boost the adoption of needles and syringes that seem to securely deliver drugs into the body system. Moreover, increasing vaccination rates were also expected to enhance the demand for novel injectable solutions, worldwide.

  • Various favorable government regulations would increase the hypodermic needle market growth.

Various patients living with diabetes and asthma condition have been utilizing hypodermic needles on their own. These patients needed to desensitize drugs and infusions in case of distinctive unfavorably susceptible reactions. Governments around the world have been facilitating the directions and laws that permit patients to carry hypodermic needles without any major confinements. For example, in March 2021, the Maryland Senate in the United States reported the passing of a novel bill decriminalizing the dispersion and ownership of hypodermic needles.

In addition, in October 2021, the New York Government reported the passing of a bill decriminalizing the distribution and sales of hypodermic needles within the state. Beneath this novel bill, hypodermic needles would not be considered as medicate gear. The government stated that the novel bill had been introduced to enhance the accessibility of the drug delivery systems to the people.

Company Product:

  • B Braun(TM) Hypodermic Needles- B Braun(TM) Hypodermic Needles are designed for patient comfort with a smooth surface, light silicone coating, automated grinding and polishing process, low-friction lubrication, transparent hub design, color-coded hubs conforming to ISO 6009, and wide range of diameters and lengths.
  • Safetouch Hypodermic Needles- Nipro's Safetouch hypodermic needles are a user-friendly, high-quality product with a transparent safety device that locks the needle inside the cover, reducing the risk of needlestick injuries for both patients and healthcare professionals.
  • Monoject(TM) Hypodermic Safety Needles- The Monoject(TM) Hypodermic Safety Needle from Cardinal Health Inc. is a user-friendly, one-handed device that provides protection with just a thumb, enhancing clinician comfort and confidence. It features double-lock hinged arm technology, ensuring safety during use and after disposal. The device also features a reversible Audible and tactile click for safety activation. It is sterile, single-use, and individually packaged, making it a convenient and safe option for clinicians.

Key Developments:

  • May 2023- High-performance abrasives are crucial for the manufacturing of hypodermic needles, ensuring smooth surfaces and precise beveling angles. Norton Abrasives offers tools for cutting, grinding, and polishing, delivering exceptional results and improving process efficiency and patient comfort.
  • January 2023- MTD Group received FDA clearance for its DropSafeTM SicuraTM passive safety needle for intramuscular and subcutaneous injection of vaccines and drugs. The needle is designed to eliminate needlestick injuries and provide a fully safe injection experience. The needle is protected by a transparent shield that automatically locks after injection, requiring no incremental activation step by healthcare professionals. The device fulfills an unmet need for increased safety in the US and is CE certification pending.

Segmentation:

Global Hypodermic Needle Market is segmented and analyzed as below:

By Type

  • Safety Hypodermic Needle
  • Non-Safety Hypodermic Needle

By Application

  • Vaccination
  • Drug delivery
  • Body Fluid Sample Collection

By End Users

  • Hospitals and Clinics
  • Ambulatory Care Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL HYPODERMIC NEEDLE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Safety Hypodermic Needle
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Non-Safety Hypodermic Needle
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. GLOBAL HYPODERMIC NEEDLE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Vaccination
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Drug delivery
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Body Fluid Sample Collection
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL HYPODERMIC NEEDLE MARKET BY END USERS

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ambulatory Care Centers
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL HYPODERMIC NEEDLE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. UK
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Italy
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. South Africa
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Thailand
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Taiwan
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. B. Braun Melsungen AG
  • 10.2. NIPRO
  • 10.3. Cardinal Health Inc.
  • 10.4. Terumo Medical Corporation
  • 10.5. Smith's Group Plc
  • 10.6. BD
  • 10.7. Iscon Surgicals Ltd.
  • 10.8. Narang Medical Ltd.
  • 10.9. Medline Industries Inc.
  • 10.10. Dynarex Corporation